Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

Given the urgent need for treatments during the coronavirus disease 2019 pandemic, the US Food and Drug Administration issued emergency use authorizations (EUAs) for multiple therapies. In several instances, however, these EUAs were issued before sufficient evidence of a given therapy’s efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhimraj, Adarsh, Morgan, Rebecca L, Shumaker, Amy Hirsch, Lavergne, Valery, Baden, Lindsey, Cheng, Vincent Chi-Chung, Edwards, Kathryn M, Gandhi, Rajesh T, Gallagher, Jason C, Muller, William J, O’Horo, John C, Shoham, Shmuel, Wollins, Dana Swartzberg, Falck-Ytter, Yngve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574541/
https://www.ncbi.nlm.nih.gov/pubmed/34668010
http://dx.doi.org/10.1093/cid/ciab880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574541/
https://www.ncbi.nlm.nih.gov/pubmed/34668010
http://dx.doi.org/10.1093/cid/ciab880

Ejemplares similares